A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

The escalating bird flu crisis is ravaging the nation's egg supply, and that shortage has hit Arizona along with the rest of ...

According to the Centers for Disease Control and Prevention (CDC), there have been 67 confirmed human cases of H5N1 bird flu ...

Going out to breakfast with the family? Well, if you plan on going to Waffle House, you’re going to have to pay a little ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

The funding awarded to Moderna for the development of an mRNA vaccine against avian flu H5N1 represents a significant step in pandemic preparedness. The combination of government investment and ...

In November, virologist Beata Halassy announced to the world that she had cured her own breast cancer using a treatment ...

A new H5N1 strain has been spotted in cows and New York is temporarily closing live poultry markets, among other warning ...